267 related articles for article (PubMed ID: 24696030)
1. Antifungal drug susceptibility and phylogenetic diversity among Cryptococcus isolates from dogs and cats in North America.
Singer LM; Meyer W; Firacative C; Thompson GR; Samitz E; Sykes JE
J Clin Microbiol; 2014 Jun; 52(6):2061-70. PubMed ID: 24696030
[TBL] [Abstract][Full Text] [Related]
2. Cryptococcus neoformans-Cryptococcus gattii species complex: an international study of wild-type susceptibility endpoint distributions and epidemiological cutoff values for fluconazole, itraconazole, posaconazole, and voriconazole.
Espinel-Ingroff A; Aller AI; Canton E; Castañón-Olivares LR; Chowdhary A; Cordoba S; Cuenca-Estrella M; Fothergill A; Fuller J; Govender N; Hagen F; Illnait-Zaragozi MT; Johnson E; Kidd S; Lass-Flörl C; Lockhart SR; Martins MA; Meis JF; Melhem MS; Ostrosky-Zeichner L; Pelaez T; Pfaller MA; Schell WA; St-Germain G; Trilles L; Turnidge J
Antimicrob Agents Chemother; 2012 Nov; 56(11):5898-906. PubMed ID: 22948877
[TBL] [Abstract][Full Text] [Related]
3. Molecular typing and in vitro antifungal susceptibility of Cryptococcus spp from patients in Midwest Brazil.
Favalessa OC; de Paula DA; Dutra V; Nakazato L; Tadano T; Lazera Mdos S; Wanke B; Trilles L; Walderez Szeszs M; Silva D; Hahn RC
J Infect Dev Ctries; 2014 Aug; 8(8):1037-43. PubMed ID: 25116671
[TBL] [Abstract][Full Text] [Related]
4. Molecular epidemiology reveals genetic diversity amongst isolates of the Cryptococcus neoformans/C. gattii species complex in Thailand.
Kaocharoen S; Ngamskulrungroj P; Firacative C; Trilles L; Piyabongkarn D; Banlunara W; Poonwan N; Chaiprasert A; Meyer W; Chindamporn A
PLoS Negl Trop Dis; 2013; 7(7):e2297. PubMed ID: 23861989
[TBL] [Abstract][Full Text] [Related]
5. Molecular epidemiology and in vitro antifungal susceptibility testing of 108 clinical Cryptococcus neoformans sensu lato and Cryptococcus gattii sensu lato isolates from Denmark.
Hagen F; Hare Jensen R; Meis JF; Arendrup MC
Mycoses; 2016 Sep; 59(9):576-84. PubMed ID: 27061834
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of antifungal combination against Cryptococcus spp.
Reichert-Lima F; Busso-Lopes AF; Lyra L; Peron IH; Taguchi H; Mikami Y; Kamei K; Moretti ML; Schreiber AZ
Mycoses; 2016 Sep; 59(9):585-93. PubMed ID: 27135278
[TBL] [Abstract][Full Text] [Related]
7. Multilocus sequence typing (MLST) and M13 PCR fingerprinting revealed heterogeneity amongst Cryptococcus species obtained from Italian veterinary isolates.
Danesi P; Firacative C; Cogliati M; Otranto D; Capelli G; Meyer W
FEMS Yeast Res; 2014 Sep; 14(6):897-909. PubMed ID: 24981157
[TBL] [Abstract][Full Text] [Related]
8. Genotypic Diversity and Antifungal Susceptibility of Clinical Isolates of Cryptococcus Gattii Species Complex from Argentina.
Taverna CG; Arias BA; Firacative C; Vivot ME; Szusz W; Vivot W; Mazza M; Córdoba SB; Canteros CE
Mycopathologia; 2023 Apr; 188(1-2):51-61. PubMed ID: 36609823
[TBL] [Abstract][Full Text] [Related]
9. Environmental sampling of Ceratonia siliqua (carob) trees in Spain reveals the presence of the rare Cryptococcus gattii genotype AFLP7/VGIV.
Linares C; Colom MF; Torreblanca M; Esteban V; Romera Á; Hagen F
Rev Iberoam Micol; 2015; 32(4):269-72. PubMed ID: 25900707
[TBL] [Abstract][Full Text] [Related]
10. Molecular typing and antifungal susceptibility of clinical isolates of Cryptococcus neoformans and Cryptococcus gattii species complexes from the National Invasive Fungal Surveillance Network of Uruguay.
Puime CA; Bórmida V; Pan D
Med Mycol; 2023 Jul; 61(7):. PubMed ID: 37336574
[TBL] [Abstract][Full Text] [Related]
11. Regional pattern of the molecular types of Cryptococcus neoformans and Cryptococcus gattii in Brazil.
Trilles L; Lazéra Mdos S; Wanke B; Oliveira RV; Barbosa GG; Nishikawa MM; Morales BP; Meyer W
Mem Inst Oswaldo Cruz; 2008 Aug; 103(5):455-62. PubMed ID: 18797758
[TBL] [Abstract][Full Text] [Related]
12. Population diversity and virulence characteristics of Cryptococcus neoformans/C. gattii species complexes isolated during the pre-HIV-pandemic era.
Pharkjaksu S; Kwon-Chung KJ; Bennett JE; Ngamskulrungroj P
PLoS Negl Trop Dis; 2020 Oct; 14(10):e0008651. PubMed ID: 33017391
[TBL] [Abstract][Full Text] [Related]
13. Molecular typing, in vitro susceptibility and virulence of Cryptococcus neoformans/Cryptococcus gattii species complex clinical isolates from south-eastern Brazil.
Grizante Barião PH; Tonani L; Cocio TA; Martinez R; Nascimento É; von Zeska Kress MR
Mycoses; 2020 Dec; 63(12):1341-1351. PubMed ID: 32869413
[TBL] [Abstract][Full Text] [Related]
14. Diversity and Antifungal Drug Susceptibility of Cryptococcus Isolates in Thailand.
Worasilchai N; Tangwattanachuleeporn M; Meesilpavikkai K; Folba C; Kangogo M; Groß U; Weig M; Bader O; Chindamporn A
Med Mycol; 2017 Aug; 55(6):680-685. PubMed ID: 27915307
[TBL] [Abstract][Full Text] [Related]
15. Genetic diversity of the Cryptococcus species complex suggests that Cryptococcus gattii deserves to have varieties.
Ngamskulrungroj P; Gilgado F; Faganello J; Litvintseva AP; Leal AL; Tsui KM; Mitchell TG; Vainstein MH; Meyer W
PLoS One; 2009 Jun; 4(6):e5862. PubMed ID: 19517012
[TBL] [Abstract][Full Text] [Related]
16. Molecular typing of clinical isolates of Cryptococcus neoformans/Cryptococcus gattii species complex from Northeast Mexico.
González GM; Casillas-Vega N; Garza-González E; Hernández-Bello R; Rivera G; Rodríguez JA; Bocanegra-Garcia V
Folia Microbiol (Praha); 2016 Jan; 61(1):51-6. PubMed ID: 26109075
[TBL] [Abstract][Full Text] [Related]
17. Molecular characterization and antifungal susceptibility testing of Cryptococcus neoformans sensu stricto from southern Brazil.
Herkert PF; Meis JF; Lucca de Oliveira Salvador G; Rodrigues Gomes R; Aparecida Vicente V; Dominguez Muro M; Lameira Pinheiro R; Lopes Colombo A; Vargas Schwarzbold A; Sakuma de Oliveira C; Simão Ferreira M; Queiroz-Telles F; Hagen F
J Med Microbiol; 2018 Apr; 67(4):560-569. PubMed ID: 29461182
[TBL] [Abstract][Full Text] [Related]
18. Molecular types of Cryptococcus neoformans and Cryptococcus gattii in Western Australia and correlation with antifungal susceptibility.
Lee GA; Arthur I; Merritt A; Leung M
Med Mycol; 2019 Nov; 57(8):1004-1010. PubMed ID: 30649538
[TBL] [Abstract][Full Text] [Related]
19. Molecular characterisation of the causative agents of Cryptococcosis in patients of a tertiary healthcare facility in the state of Amazonas-Brazil.
Freire AK; dos Santos Bentes A; de Lima Sampaio I; Matsuura AB; Ogusku MM; Salem JI; Wanke B; de Souza JV
Mycoses; 2012 May; 55(3):e145-50. PubMed ID: 22360142
[TBL] [Abstract][Full Text] [Related]
20. Identification of novel hybrids between Cryptococcus neoformans var. grubii VNI and Cryptococcus gattii VGII.
Aminnejad M; Diaz M; Arabatzis M; Castañeda E; Lazera M; Velegraki A; Marriott D; Sorrell TC; Meyer W
Mycopathologia; 2012 Jun; 173(5-6):337-46. PubMed ID: 22081254
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
